Literature DB >> 26112331

Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.

Angélica P Escobar1,2, Francisca A Cornejo1,2, Montserrat Olivares-Costa1,2, Marcela González1,2, José A Fuentealba1,3, Katia Gysling1,2, Rodrigo A España4, María E Andrés1,2.   

Abstract

Dopamine from the ventral tegmental area and glutamate from several brain nuclei converge in the nucleus accumbens (NAc) to drive motivated behaviors. Repeated activation of D2 receptors with quinpirole (QNP) induces locomotor sensitization and compulsive behaviors, but the mechanisms are unknown. In this study, in vivo microdialysis and fast scan cyclic voltammetry in adult anesthetized rats were used to investigate the effect of repeated QNP on dopamine and glutamate neurotransmission within the NAc. Following eight injections of QNP, a significant decrease in phasic and tonic dopamine release was observed in rats that displayed locomotor sensitization. Either a systemic injection or the infusion of QNP into the NAc decreased dopamine release, and the extent of this effect was similar in QNP-sensitized and control rats, indicating that inhibitory D2 autoreceptor function is maintained despite repeated activation of D2 receptors and decreased dopamine extracellular levels. Basal extracellular levels of glutamate in the NAc were also significantly lower in QNP-treated rats than in controls. Moreover, the increase in NAc glutamate release induced by direct stimulation of medial prefrontal cortex was significantly lower in QNP-sensitized rats. Together, these results indicate that repeated activation of D2 receptors disconnects NAc from medial prefrontal cortex and ventral tegmental area. Repeated administration of the dopamine D2 receptor agonist quinpirole (QNP) induces locomotor sensitization. We found that the NAc of QNP-sensitized rats has reduced glutamate levels coming from prefrontal cortex together with a decreased phasic and tonic dopamine neurotransmission but a conserved presynaptic D2 receptor function. We suggest that locomotor sensitization is because of increased affinity state of D2 post-synaptic receptors.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  dopamine; fast scan cyclic voltammetry; glutamate; microdialysis; nucleus accumbens; quinpirole

Mesh:

Substances:

Year:  2015        PMID: 26112331     DOI: 10.1111/jnc.13209

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  GPRIN3 Controls Neuronal Excitability, Morphology, and Striatal-Dependent Behaviors in the Indirect Pathway of the Striatum.

Authors:  Deniz Karadurmus; Daniel Rial; Jean-François De Backer; David Communi; Alban de Kerchove d'Exaerde; Serge N Schiffmann
Journal:  J Neurosci       Date:  2019-07-30       Impact factor: 6.167

Review 2.  Validity of Quinpirole Sensitization Rat Model of OCD: Linking Evidence from Animal and Clinical Studies.

Authors:  Ales Stuchlik; Dominika Radostová; Hana Hatalova; Karel Vales; Tereza Nekovarova; Jana Koprivova; Jan Svoboda; Jiri Horacek
Journal:  Front Behav Neurosci       Date:  2016-10-26       Impact factor: 3.558

3.  Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.

Authors:  Angélica P Escobar; Marcela P González; Rodrigo C Meza; Verónica Noches; Pablo Henny; Katia Gysling; Rodrigo A España; José A Fuentealba; María E Andrés
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

4.  Neuroreceptor kinetics in rats repeatedly exposed to quinpirole as a model for OCD.

Authors:  Stijn Servaes; Dorien Glorie; Sigrid Stroobants; Steven Staelens
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

5.  Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.

Authors:  Katharine Pillidge; Ashley J Porter; Jared W Young; S Clare Stanford
Journal:  J Psychopharmacol       Date:  2016-04-19       Impact factor: 4.153

Review 6.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.